Principles of Cancer Therapy - Other Modalities

Key points
- Endocrine Therapy Additive or ablative endocrine therapy can influence the course of some cancers.
- Interferons have demonstrated activity in selected cancers.
- Similarly, estrogen ablation (by oophorectomy) provides palliation in advanced breast cancer.
- Biologic Response Modifiers Interferons, interleukins, and tumor necrosis factor (TNF) are biologic proteins that function in immune (protective) responses.
Endocrine Therapy
Additive or ablative endocrine therapy can influence the course of some cancers. Endocrine therapy is not curative; it is only palliative. Orchiectomy has significant palliative value in metastatic prostate cancer, commonly prolonging survival 3 to 5 yr. Its efficacy is based on the testosterone-dependent population of prostate cancer cells. Other cancers with hormone receptors on their cells (eg, breast, endometrium, ovary) can often be palliated by hormone ablative therapy. This success led to the use of hormones as pharmacologic therapy for such tumors. Estrogen effectively palliates prostate cancer but increases the risk of heart disease. These observations led to treatment with gonadotropin secretory inhibitors. Leuprolide, a synthetic analog of gonadotropin-releasing hormone, inhibits gonadotropin secretion and resultant gonadal androgen production and is as effective for the palliation of prostate cancer as is orchiectomy. Even more complete androgen blockage can be achieved by adding an oral antiandrogen (flutamide or bicalutamide), which limits androgen binding to its receptor; this combination appears to increase disease-free survival by 6 to 12 mo over leuprolide or orchiectomy alone.
Similarly, estrogen ablation (by oophorectomy) provides palliation in advanced breast cancer. Tamoxifen, an oral hormone, can bind to estrogen receptors on breast cancer cells and is as effective for palliation as is oophorectomy. It is a particularly effective therapy for metastatic breast cancer in the postmenopausal woman. As an adjuvant therapy in breast cancer, it prolongs the duration of disease-free survival, improves cure rate in receptor-positive patients by 20 to 30%, and reduces the risk of contralateral breast cancer by about 60%. For details of endocrine therapy, see Table 144-2.
Biologic Response Modifiers
Interferons, interleukins, and tumor necrosis factor (TNF) are biologic proteins that function in immune (protective) responses. They are synthesized by cells of the immune system when invaded by viruses as a physiologic protective response. In pharmacologic amounts, they have palliative efficacy in some cancers.
Principles of Cancer Therapy
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew study reveals how to improve chemotherapy use in prostate cancer
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease. A study published online this week (January 17th) in…
18 February 2015
NewsNew method shrinks metastatic ovarian cancer and reduces chemotherapy dose
New research published in the February 2015 issue of The FASEB Journal, may eventually help improve the five-year survival rate of ovarian cancer patients by describing a new way of shrinking ovarian cancer tumors while…
3 February 2015
NewsSome older cancer patients can avoid radiotherapy, study finds
Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown. Older women with early breast cancer who are given breast-conserving surgery and hormone…







